Not according to ETrisk.com platelet normalization does not equate to disease control. Studies have shown that commonly used therapies—aspirin, hydroxyurea (HU), and anagrelide—have minimal impact on the continuous clonal proliferation in the bone marrow
Common existing treatments—aspirin, HU, and anagrelide—do not modify the underlying biologic drivers of ET, leaving patients at risk for complications such as MF or AML.Despite advances in our understanding of ET, FDA-approved treatment options… read more
No, it does not.
Does platelet normalization mean the disease is controlled?
You've touched on an important distinction in ET treatment. Normalizing platelet counts doesn't necessarily mean controlling the underlying disease process itself.
Current treatments like aspirin, hydroxyurea, and anagrelide primarily focus on managing symptoms Show Full Answer